Related Experiment Video
Updated: Aug 9, 2026

Analyzing Telomeric Protein-DNA Interactions Using Single-Molecule Magnetic Tweezers
Published on: August 30, 2024
E2F1 and telomerase: alliance in the dark side
Marta M Alonso1, Juan Fueyo, W K Alfred Yung
1Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Abstract:
Cancer arises from a stepwise accumulation of genetic changes. Among these changes, deregulation of the Rb/E2F1 pathway and constitutively active telomerase are pivotal milestones for the attainment of immortality and maintaining the neoplastic phenotype. We recently showed the Rb/E2F1 pathway to be a direct modulator of telomerase activity in normal and cancer cells, specifically in malignant gliomas. In addition, we reported that the correlation between the levels of expression of E2F1 and hTERT -the catalytic subunit of telomerase- in a subset of patients with glioblastoma multiforme confers clinical relevance to the role of E2F1 in triggering or maintaining hTERT expression. Here we review the evidence supporting the mechanistic linkage between E2F1 and telomerase activation. We also consider the clinical implications of this association in terms of prognostic significance and opportunities for the development of new and more rational therapeutic strategies.
Insights
The Rb/E2F1 pathway directly regulates telomerase activity, a key factor in cancer cell immortality. This link between E2F1 and human telomerase reverse transcriptase (hTERT) has clinical implications for glioblastoma prognosis and therapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer development involves genetic alterations, including Rb/E2F1 pathway deregulation and active telomerase, enabling cell immortality.
- The Rb/E2F1 pathway and telomerase are crucial for cancer cell immortality and maintaining the neoplastic phenotype.
Purpose of the Study:
- To review evidence linking the Rb/E2F1 pathway to telomerase activation.
- To explore the clinical relevance of the E2F1-telomerase association in glioblastoma.
Main Methods:
- Review of existing scientific literature and data.
- Analysis of gene expression correlations in glioblastoma patient samples.
Main Results:
- The Rb/E2F1 pathway directly modulates telomerase activity in normal and cancer cells.
- Expression levels of E2F1 correlate with human telomerase reverse transcriptase (hTERT) in glioblastoma, indicating clinical relevance.
Conclusions:
- A mechanistic link exists between E2F1 and telomerase activation.
- This association offers prognostic significance and potential for novel therapeutic strategies in glioblastoma.
Related Concept Videos
Telomeres and Telomerase
Telomeres and Telomerase
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Replication in Eukaryotes
Replicative Cell Senescence
Replicative Cell Senescence
